UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

S1651 Association of Leptin-Melanocortin Pathway Genetic Variants and Obesity-Related Phenotypic Traits

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S1236-S1237

2023

Volltextzugriff (PDF)

S1666 Association of Resting Energy Expenditure and Satiation Parameters in Patients With Obesity

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S1246-S1246

2023

Volltextzugriff (PDF)

S1485 Semaglutide Outcomes in Non-Alcoholic Fatty Liver Disease: A Multi-Centered Real-World Study

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S1127-S1128

2023

Volltextzugriff (PDF)

S1648 Cardiovascular Disease Risk Improvement With Semaglutide in Patients With Obesity: A Multi-Centered Study

The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S1234-S1235

2023

Volltextzugriff (PDF)

Quantifying alcohol use among Ecuadorian human immunodeficiency virus positive individuals and assessing alcohol as an independent risk factor for human immunodeficiency virus: A case control study STROBE

Medicine (Baltimore), 2020-11, Vol.99 (48), p.e23276

2020

Volltextzugriff (PDF)

Su1918 EFFICACY OF ANTIOBESITY MEDICATIONS ON WEIGHT LOSS OUTCOMES IN PATIENTS WITH A TRANSORAL OUTLET REDUCTION AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-713-S-714

2023

Volltextzugriff (PDF)

Publication rate and citation counts for preprints released during the COVID-19 pandemic: the good, the bad and the ugly

PeerJ (San Francisco, CA), 2021-03, Vol.9, p.e10927-e10927, Article e10927

2021

Volltextzugriff (PDF)

Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist

Clinical gastroenterology and hepatology, 2024-06, Vol.22 (6), p.1333-1335.e2

2024

Volltextzugriff (PDF)

840 IMPACT OF HETEROZYGOUS GENETIC VARIANTS IN THE LEPTIN-MELANOCORTIN PATHWAY ON WEIGHT LOSS OUTCOMES FOLLOWING ENDOSCOPIC TRANSORAL OUTLET REDUCTION AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-180-S-180

2023

Volltextzugriff (PDF)

Mo1921 EFFICACY OF ANTIOBESITY MEDICATIONS ON WEIGHT LOSS OUTCOMES IN PATIENTS WITH CELIAC DISEASE

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-940-S-941

2023

Volltextzugriff (PDF)

Cumulative effect of obesity phenotypes on body weight and body mass index

International Journal of Obesity, 2024-06, Vol.48 (6), p.884-890

2024

Volltextzugriff (PDF)

Performance Characteristics of Polygenic Risk Score for Satiation in Food Intake Regulation

Obesity (Silver Spring, Md.), 2023-11, Vol.31, p.236-237

2023

Volltextzugriff (PDF)

Weight Loss Response to Semaglutide in Menopausal Women with and without Menopausal Hormone Therapy

Obesity (Silver Spring, Md.), 2023-11, Vol.31, p.169-169

2023

Volltextzugriff (PDF)

Tu1919 HIGH PROTEIN DIET PRESCRIPTIONS FOR WEIGHT LOSS IMPAIRS POSTPRANDIAL BRANCHED CHAIN AMINO ACID UTILIZATION

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-1161-S-1162

2023

Volltextzugriff (PDF)

702 WEIGHT LOSS OUTCOMES WITH SEMAGLUTIDE BASED ON DIABETES STATUS AND SEVERITY USING THE INDIVIDUALIZED METABOLIC SURGERY SCORE

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-144-S-144

2023

Volltextzugriff (PDF)

Mo1917 PREVIOUS ANTI-OBESITY MEDICATION INFLUENCES THE WEIGHT LOSS OUTCOMES OF SEMAGLUTIDE TREATMENT FOR OBESITY

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-938-S-939

2023

Volltextzugriff (PDF)

638 PERFORMANCE OF A MACHINE-LEARNING GENE RISK SCORE BIOMARKER ON PREDICTING RESPONSE TO SEMAGLUTIDE: A PROSPECTIVELY FOLLOWED MULTI-CENTER BIOBANK AND OUTCOMES REGISTRY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-148-S-148

2024

Volltextzugriff (PDF)

Sa1951 CLINICAL PARAMETERS ASSOCIATED WITH SEMAGLUTIDE INTOLERANCE IN PATIENTS WITH DIABETES AND OBESITY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-591-S-592

2024

Volltextzugriff (PDF)

983 SHORT- AND LONG-TERM GUT MUCOSAL ADAPTATIONS TO DIETINDUCED WEIGHT LOSS COMPARED TO ROUX-EN-Y-INDUCED WEIGHT LOSS IN PATIENTS WITH OBESITY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-237-S-238

2024

Volltextzugriff (PDF)

Su1945 NEURAL FOOTPRINTS OF THE VISCERAL, HOMEOSTATIC, AND HEDONIC COMPONENTS OF FOOD INTAKE REGULATION IN HUMANS: THE PHYSIOLOGICAL REGULATION OF ENERGY INTAKE (FOOD-PRINT) EXPLORATORY PROOF-OF-FEASIBILITY STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-879-S-880

2024

Volltextzugriff (PDF)

1283 SATIATION TESTING AND A SURROGATE MACHINE-LEARNING ASSISTED GENE RISK SCORE BIOMARKER PREDICT DIFFERENTIAL RESPONSES TO LIFESTYLE INTERVENTIONS: A POST-HOC ANALYSIS OF A SINGLE CENTER, NON-RANDOMIZED CLINICAL TRIAL

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-306-S-307

2024

Volltextzugriff (PDF)

EFFICACY OF ANTI-OBESITY MEDICATIONS IN PATIENTS WITH LEPTIN-MELANOCORTIN PATHWAY HETEROZYGOUS VARIANTS POST-ENDOSCOPIC TRANSORAL OUTLET REDUCTION IN ROUX-EN-Y GASTRIC BYPASS

Gastrointestinal endoscopy, 2024-06, Vol.99 (6), p.AB57-AB58

2024

Volltextzugriff (PDF)

A Polygenic Risk Score to Identify Abnormal Satiation Predicts Response to Phentermine-Topiramate ER

Obesity (Silver Spring, Md.), 2023-11, Vol.31, p.48-48

2023

Volltextzugriff (PDF)

Mo1915 REAL-WORLD WEIGHT LOSS AND METABOLIC PARAMETERS OUTCOMES OF SEMAGLUTIDE: A 1-YEAR MULTI-SITE STUDY

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-937-S-938

2023

Volltextzugriff (PDF)

Su1910 ENDOSCOPIC REVISION OF PRIMARY BARIATRIC AND ENDOBARIATRIC PROCEDURES: COMPARISON OF WEIGHT LOSS OUTCOMES AND SAFETY

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-710-S-710

2023

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(68)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(21)
Covid-19
(15)
Humans
(14)
Obesity
(13)
Female
(10)
Male
(9)
Sars-Cov-2
(9)
Latin America
(8)
Weight Control
(8)
Adult
(7)
Coronaviruses
(7)
Middle Aged
(7)
Pandemics
(7)
Vaccination
(7)
Covid-19 Vaccines
(6)
Gastrointestinal Surgery
(6)
Vaccination Refusal
(6)
Peru
(5)
Severe Acute Respiratory Syndrome Coronavirus 2
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

S1651 Association of Leptin-Melanocortin Pathway Genetic Variants and Obesity-Related Phenotypic Traits

S1666 Association of Resting Energy Expenditure and Satiation Parameters in Patients With Obesity

S1485 Semaglutide Outcomes in Non-Alcoholic Fatty Liver Disease: A Multi-Centered Real-World Study

S1648 Cardiovascular Disease Risk Improvement With Semaglutide in Patients With Obesity: A Multi-Centered Study

Quantifying alcohol use among Ecuadorian human immunodeficiency virus positive individuals and assessing alcohol as an independent risk factor for human immunodeficiency virus: A case control study STROBE

Su1918 EFFICACY OF ANTIOBESITY MEDICATIONS ON WEIGHT LOSS OUTCOMES IN PATIENTS WITH A TRANSORAL OUTLET REDUCTION AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY

Publication rate and citation counts for preprints released during the COVID-19 pandemic: the good, the bad and the ugly

Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist

840 IMPACT OF HETEROZYGOUS GENETIC VARIANTS IN THE LEPTIN-MELANOCORTIN PATHWAY ON WEIGHT LOSS OUTCOMES FOLLOWING ENDOSCOPIC TRANSORAL OUTLET REDUCTION AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY

Mo1921 EFFICACY OF ANTIOBESITY MEDICATIONS ON WEIGHT LOSS OUTCOMES IN PATIENTS WITH CELIAC DISEASE

Cumulative effect of obesity phenotypes on body weight and body mass index

Performance Characteristics of Polygenic Risk Score for Satiation in Food Intake Regulation

Weight Loss Response to Semaglutide in Menopausal Women with and without Menopausal Hormone Therapy

Tu1919 HIGH PROTEIN DIET PRESCRIPTIONS FOR WEIGHT LOSS IMPAIRS POSTPRANDIAL BRANCHED CHAIN AMINO ACID UTILIZATION

702 WEIGHT LOSS OUTCOMES WITH SEMAGLUTIDE BASED ON DIABETES STATUS AND SEVERITY USING THE INDIVIDUALIZED METABOLIC SURGERY SCORE

Mo1917 PREVIOUS ANTI-OBESITY MEDICATION INFLUENCES THE WEIGHT LOSS OUTCOMES OF SEMAGLUTIDE TREATMENT FOR OBESITY

638 PERFORMANCE OF A MACHINE-LEARNING GENE RISK SCORE BIOMARKER ON PREDICTING RESPONSE TO SEMAGLUTIDE: A PROSPECTIVELY FOLLOWED MULTI-CENTER BIOBANK AND OUTCOMES REGISTRY

Sa1951 CLINICAL PARAMETERS ASSOCIATED WITH SEMAGLUTIDE INTOLERANCE IN PATIENTS WITH DIABETES AND OBESITY

983 SHORT- AND LONG-TERM GUT MUCOSAL ADAPTATIONS TO DIETINDUCED WEIGHT LOSS COMPARED TO ROUX-EN-Y-INDUCED WEIGHT LOSS IN PATIENTS WITH OBESITY

Su1945 NEURAL FOOTPRINTS OF THE VISCERAL, HOMEOSTATIC, AND HEDONIC COMPONENTS OF FOOD INTAKE REGULATION IN HUMANS: THE PHYSIOLOGICAL REGULATION OF ENERGY INTAKE (FOOD-PRINT) EXPLORATORY PROOF-OF-FEASIBILITY STUDY

1283 SATIATION TESTING AND A SURROGATE MACHINE-LEARNING ASSISTED GENE RISK SCORE BIOMARKER PREDICT DIFFERENTIAL RESPONSES TO LIFESTYLE INTERVENTIONS: A POST-HOC ANALYSIS OF A SINGLE CENTER, NON-RANDOMIZED CLINICAL TRIAL

EFFICACY OF ANTI-OBESITY MEDICATIONS IN PATIENTS WITH LEPTIN-MELANOCORTIN PATHWAY HETEROZYGOUS VARIANTS POST-ENDOSCOPIC TRANSORAL OUTLET REDUCTION IN ROUX-EN-Y GASTRIC BYPASS

A Polygenic Risk Score to Identify Abnormal Satiation Predicts Response to Phentermine-Topiramate ER

Mo1915 REAL-WORLD WEIGHT LOSS AND METABOLIC PARAMETERS OUTCOMES OF SEMAGLUTIDE: A 1-YEAR MULTI-SITE STUDY

Su1910 ENDOSCOPIC REVISION OF PRIMARY BARIATRIC AND ENDOBARIATRIC PROCEDURES: COMPARISON OF WEIGHT LOSS OUTCOMES AND SAFETY

Suchergebnisse filtern